Analysts expect over 2018 decreasing revenue Merck KGaA

Tomorrow the German Merck KGaA KGaA will report its past quarter's results. Over the current book year the total revenue will be 15,11 billion euros (consensus estimates). This is slightly lower than 2016's revenue of 15,33 billion euros.

Historical revenues and results Merck KGaA KGaA plus estimates 2018

The analysts expect for 2018 a net profit of 2,34 billion euros. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 5,59 euros. Based on this the price/earnings-ratio is 14,91.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the pharmaceutical companies equals a poor 1 percent.

Most recent target prices around 88 euros

The most recent recommendations for the pharmaceutical company are from JP Morgan, Credit Suisse and Societe Generale .

Merck KGaA KGaA's market value equals around 10,77 billion .

At 11.35 the stock trades 2,06 percent higher at 83,32 euros.

Historical stock prices Merck KGaA KGaA

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.